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PIEZO1 is a cation channel that is activated by mechanical forces
such as fluid shear stress or membrane stretch. PIEZO1 loss-of-
function mutations in patients are associated with congenital lym-
phedema with pleural effusion. However, the mechanistic link be-
tween PIEZO1 function and the development or function of the
lymphatic system is currently unknown. Here, we analyzed two mouse
lines lacking PIEZO1 in endothelial cells (via Tie2Cre or Lyve1Cre) and
found that they exhibited pleural effusion and died postnatally.
Strikingly, the number of lymphatic valves was dramatically re-
duced in these mice. Lymphatic valves are essential for ensuring
proper circulation of lymph. Mechanical forces have been implicated
in the development of lymphatic vasculature and valve formation,
but the identity of mechanosensors involved is unknown. Expression
of FOXC2 and NFATc1, transcription factors known to be required for
lymphatic valve development, appeared normal in Tie2Cre;Piezo1cKO
mice. However, the process of protrusion in the valve leaflets, which
is associated with collective cell migration, actin polymerization, and
remodeling of cell–cell junctions, was impaired in Tie2Cre;Piezo1cKO
mice. Consistent with these genetic findings, activation of PIEZO1 by
Yoda1 in cultured lymphatic endothelial cells induced active remod-
eling of actomyosin and VE-cadherin+ cell–cell adhesion sites. Our
analysis provides evidence that mechanically activated ion channel
PIEZO1 is a key regulator of lymphatic valve formation.
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The lymphatic system is essential for fluid homeostasis in thebody. Lymphatic vessels collect extracellular fluid from the
interstitial space and drain it back to the venous circulation (1, 2).
The lymphatic system is also involved in absorption of fat from the
gut and is important for coordinating adaptive immune responses.
Its dysfunction often results in peripheral lymphedema as well as
pleural effusions and ascites. Lymphatic valves are required to
ensure unidirectional flow of lymph in collecting vessels that are
composed of contractile units known as lymphangions. The valves
are formed from lymphatic endothelial cells (LECs), the main
component of the lymphatic vasculature. Mouse genetic studies have
identified transcription factors, adhesion proteins, and mediators of
intercellular signaling as essential components for the development
and maintenance of lymphatic vasculature and valves (1, 3–5). In
addition, the contribution of mechanical forces to the development
and maintenance of the lymphatic vasculature has been described
(6). Accumulating evidence suggests that genes involved in valve
formation are up-regulated when LECs are exposed to shear stress
(7, 8). However, it still remains unclear how mechanical stimuli are
converted into intracellular signals in the lymphatic endothelium.
Recently, studies of patients with familial lymphatic dysfunction
suggested that mechanically activated ion channel PIEZO1 is required
for lymphatic system function. Specifically, homozygous and com-
pound heterozygous mutations in PIEZO1 were identified among
patients suffering from persistent lymphedema, plural effusions, and
ascites associated with congenital lymphatic dysplasia (9–11). PIEZO1
and PIEZO2 are nonselective cation channels activated by mechanical
forces applied to the cell membrane, such as fluid shear stress and cell
stretching (12–16). PIEZOs are large proteins containing more than
2,000 amino acids with 38 transmembrane domains per protomer.
PIEZO1 trimeric channels form a three-bladed propeller shape with a
curved transmembrane region as revealed by cryoelectron microscopy.
It has been proposed that a change in membrane tension induces
conformational change of these propellers and leads to channel pore
opening (17–20). PIEZO2 functions as the key mechanotransducer for
light touch sensation, proprioception, and control of respiration (21–
24). PIEZO1, on the other hand, is expressed in endothelial cells,
including LECs, and plays essential roles in developing blood vessels
in mouse embryos and in flow-mediated vasoconstriction in adult
mice (8, 15, 25–28). In addition, PIEZO1 in red blood cells controls
cell volume regulation, and gain-of-function mutations in PIEZO1
cause dehydrated RBCs and some protection from malaria infection
in mice and human (29–32). In this study, we analyzed mouse lines
lacking PIEZO1 in endothelial cells and found that PIEZO1 is re-
quired for formation of lymphatic valves, highlighting the physio-
logical importance of PIEZO1 in the lymphatic system.
Results
Postnatal Pleural Effusion and Lethality of Endothelial-Specific Piezo1
Conditional Knockout Mice. We previously reported that, when
PIEZO1 is constitutively and globally ablated (Piezo1−/−), mice
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die during embryonic midgestation, with growth retardation and
defects in vascular remodeling in the yolk sac (15). To investigate
the role of PIEZO1 in the lymphatic system in detail, we gen-
erated two mouse lines in which PIEZO1 was deleted specifically
in endothelial cells.
The Tie2Cre mouse line, in which Cre recombinase is expressed
in vascular endothelial cells, including both blood (BECs) and
lymphatic endothelial cells (SI Appendix, Fig. S1A), was crossed
with Piezo1flox/flox mice to generate Tie2Cre;Piezo1cKO mice (29,
33). Tie2Cre;Piezo1cKO mice were born at the expected ratio [ac-
tual: 23.9% (28/117), expected: 25%], suggesting that they survive
past embryonic development. Previously, endothelial-specific
deletion of PIEZO1 in mice was reported to cause embryonic
lethality (25). The variation in phenotype between the two
studies could potentially be due to differences in genetic back-
ground (25, 29, 34). In our colony, most Tie2Cre;Piezo1cKO mice
died within 2 wk after birth (Fig. 1A). The body weight of the
Piezo1-deficient mice was slightly less than control littermates
during postnatal days (SI Appendix, Fig. S1B). Among human
patients with PIEZO1 loss-of-function variants, pleural effusion,
a sign of defect in the lymphatic system, especially damage of
lymphatic vessels close to the chest cavity, has been reported.
Consistently, pleural effusion was evident in 1-wk-old Tie2Cre;
Piezo1cKO mice (Fig. 1 B and C).
The second mouse line we utilized was initially aimed to more
specifically ablate PIEZO1 in lymphatic endothelial cells. Here,
Cre recombinase was expressed from the locus of lymphatic vessel
endothelial hyaluronan receptor 1 (Lyve1), a widely used marker for
LECs (5, 35–37). High efficiency of Cre-mediated recombination
of loxP sites in LECs was reported with this line; however, re-
combination in a subset of BECs was also reported (35). We ex-
amined the specificity of Cre activity in various endothelial cells by
crossing the Lyve1Cre line to the Ai9 line (loxP-stop-loxP-tdTomato
reporter in the ROSA26 locus) (38). In the mesentery of Lyve1Cre;
Ai9 mice, tdTomato signal was detected in arteries and veins, as
well as lymphatic vessels (SI Appendix, Fig. S2A). These results
were identical to what was observed for tdTomato signal in Tie2Cre;
Ai9 mesentery (SI Appendix, Fig. S1A). Therefore, Lyve1Cre;
Piezo1cKO and Tie2Cre;Piezo1cKO both appear to delete PIEZO1
from LECs as well as BECs, although the efficiency of recombi-
nation in BECs might be less in Lyve1Cre;Piezo1cKO mice (35).
Regardless, we used the Lyve1Cre;Piezo1cKO mice to confirm our
results obtained from Tie2Cre;Piezo1cKO mice.
Lyve1Cre;Piezo1cKO mice showed postnatal lethality around 1–
2 wk after birth and pleural effusion 1 wk after birth (Fig. 1 D–F),
resembling Tie2Cre;Piezo1cKO mice. In human PIEZO1-deficient
patients, respiratory defects resulting from severe pleural effu-
sion were also reported (9). In line with this, three out of four
Lyve1Cre;Piezo1cKO mice exhibited collapsed alveoli at postnatal
day 7 (P7), while this was never observed in WT mice (SI Ap-
pendix, Fig. S2B). Taken together, these mouse models exhibit
similar defects in patients with PIEZO1 loss-of-function muta-
tions, suggesting that a role of PIEZO1 in the lymphatic system is
likely conserved between human and mouse.
Reduced Number of Lymphatic Valves in Tie2Cre;Piezo1cKO and
Lyve1Cre;Piezo1cKO Mice. Next, we checked the structure of the
lymphatic vasculature of Tie2Cre;Piezo1cKO and Lyve1Cre;Piezo1cKO
mice in the mesentery, where the development of lymphatic
vasculature is well studied (7). At P4, it was evident that lym-
phatic valves, which are marked by clusters of Prox1high nuclei
and strong signal of integrin α9, were drastically reduced in
Tie2Cre;Piezo1cKO mice compared with WT littermates (Fig. 2 A
and B). Reduced numbers of lymphatic valves were also ob-
served in P4 Lyve1Cre;Piezo1cKO mice, compared with WT lit-
termates (Fig. 2 C and D). Therefore, endothelial PIEZO1 is
required for the formation and/or maintenance of lymphatic
valves. Given the similar phenotypes observed with Tie2Cre and
Lyve1Cre, we performed the rest of the analysis with Tie2Cre;
Piezo1cKO mice.
Impaired Lymphatic Valve Protrusion in Tie2Cre;Piezo1cKO Mice. Our
results suggested an almost complete absence of lymphatic valves
at postnatal day 4. Next, we checked the development of lym-
phatic valves in Tie2Cre;Piezo1cKO embryos. The development of
lymphatic valves is divided into several stages (7, 39). Up-
regulation of Prox1 expression (Prox1high) is a marker for cells
which will form valve leaflets (7, 39). First, a few Prox1high LECs
appear in the vessel (stage 1). Next, the number of Prox1high cells
increases and they align in the shape of a ring in the vessel (stage 2).
The rings of Prox1high cells are often formed around branching
points within vessels. Then, clusters of Prox1high cells further
develop into valves. During this process, Prox1high cells align
perpendicular to the vessel’s axis (reorientation) (stage 2.5).
Reoriented Prox1high cells migrate toward the lumen (valve
protrusion), resulting in disk-like structures (39) and constriction
Fig. 1. Postnatal lethality, pleural effusion in endothelial-specific Piezo1
cKO mice. (A) Survival rate of WT (n = 14), Het (Piezo1−/+ or Tie2Cre;
Piezo1+/fl) (n = 13), or Tie2Cre;Piezo1cKO (n = 14) newborn mice. (B) Chylous
pleural effusion (red arrow) observed in 1-wk-old Tie2Cre;Piezo1cKO, but not
in WT littermate. (Scale bar: 5 mm.) (C) Amount of liquid in the chest cavity
at P9. Mean ± SEM (n = 6 for WT, n = 5 for Tie2Cre;Piezo1cKO mice). *P <
0.05, unpaired t test. (D) Survival rate of WT (n = 13) or Lyve1Cre;Piezo1cKO
(n = 15) newborn mice. (E) Chylous pleural effusion (red arrows) observed in
1-wk-old Lyve1Cre;Piezo1cKOmice, but not inWT littermate. (Scale bar: 5 mm.)
(F) Amount of liquid in the chest cavity in 1-wk-old mice. Mean ± SEM (n = 16
for WT, n = 8 for Lyve1Cre;Piezo1cKO mice). *P < 0.05, unpaired t test.
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of the vessel (stage 3). The valves continue to elongate until they
form V-like shapes with leaflets in association with a thick ex-
tracellular matrix core (stage 4). Valve development is known to
commence earlier in larger diameter, more proximal lymphatic
vessels. Therefore, at embryonic day 18.5 (E18.5), valves at
different stages of development can normally be identified in
different segments of mouse mesentery. We first compared the
number of valve-forming regions (VFRs), containing ≥10
Prox1high nuclei, in E18.5 mesentery between WT and Tie2Cre;
Piezo1cKO embryos. In contrast to the nearly complete loss of
fully formed valves at P4, we observed no significant difference
in the number of VFRs between WT and Tie2Cre;Piezo1cKO
mesenteries at E18.5 (Fig. 3 A and B). Next, we checked the
proportion of VFRs at different stages based on the direction of
the major axis of Prox1high nuclei and the presence of constric-
tion in the vessel (Fig. 3C). In the mesentery of E18.5 Tie2Cre;
Piezo1cKO embryos, there was an overrepresentation of valves at
stage 2 at the expense of stages 3 and 4, compared with WT
littermates. The percentage of valves at intermediate phase
(stage 2.5) was not different between Tie2Cre;Piezo1cKO and WT
mesenteries (Fig. 3D). Next, we examined the structure of
VFRs of Tie2Cre;Piezo1cKO embryos in more detail. Previous
studies demonstrated that valve protrusion results from collec-
tive cell migration of Prox1high cells, which is associated with
actin polymerization and formation of cell–cell junctions (39,
40). In the optical cross-sections at VFRs of WT embryos,
Prox1high nuclei were observed not only on the wall of the vessel,
but also in the more central regions, a sign of cell migration,
which results in valve protrusion (Fig. 3 E and F). These
Prox1high nuclei were indeed associated with VE-cadherin and F-
actin signals (Fig. 3 E, G, and H). In the cross-sections at VFRs
of Tie2Cre;Piezo1cKO embryos, Prox1high nuclei were lined as a
single layered ring, suggesting a defect in cell migration (Fig. 3 E
and F). In addition, in these sections, signals of F-actin or VE-
cadherin were rarely observed in the more central regions than
Prox1high nuclei on the vessel wall, suggesting that structures such
as cell extension toward lumen or cell–cell junction between valve-
forming cells (that might contribute to valve protrusion) were not
formed in VFRs of Tie2Cre;Piezo1cKO embryos (Fig. 3 E, G, and
H). These data suggest that the protrusion process of lymphatic
valves is impaired in Tie2Cre;Piezo1cKO lymphatic vasculature.
We also examined valves in the veins and the heart in Tie2Cre;
Piezo1cKO mice. In P3 iliac veins, valves marked with Prox1high
nuclei were observed in WT mice but not in Tie2Cre;Piezo1cKO
mice, suggesting that PIEZO1 is also required for venous valve
formation (SI Appendix, Fig. S3A). In contrast, no obvious de-
fects were detected in the heart valves of P6 Tie2Cre;Piezo1cKO
mice (SI Appendix, Fig. S3B). Whether the deficits in venous
valve formation contribute to the pathology or lethality of
Tie2Cre;Piezo1cKO mice is not known.
Expression of Transcription Factors Involved in Valve Development in
Tie2Cre;Piezo1cKO Mice. A number of proteins, including tran-
scription factors, are specifically expressed or activated at VFRs
and are involved in the initiation of valve development (3).
Recent studies utilizing cultured LECs suggest that shear stress
induced by lymph flow is upstream and induces these changes,
implying that mechanotransduction is involved in this process (6–
8, 41). Our previous in vitro data suggested that PIEZO1 is not
required for flow-induced expression of FOXC2 and GATA2 in
LECs (8). Nuclear localization of another transcription factor
NFATc1 at VFRs is suggested to occur via Ca2+ signaling (7). To
assess the involvement of PIEZO1 in expression of transcrip-
tional factors at VFRs, we examined the distribution of FOXC2
and NFATc1 in Tie2Cre;Piezo1cKO mesentery. However, no
obvious difference was detected in the expression pattern of
FOXC2 or NFATc1 between WT and Tie2Cre;Piezo1cKO lym-
phatic vasculatures; clusters of FOXC2high or NFATc1high nuclei
were observed overlapping with Prox1high signal in both WT and
Tie2Cre;Piezo1cKO mesenteries (Fig. 4). Other transcription fac-
tors and proteins are involved in the initiation of valve devel-
opment, and it remains an open question whether PIEZO1 is
involved in such pathways. However, our in vivo data suggest that
up-regulated expression of FOXC2 and nuclear localization of
NFATc1 at VFRs, which are currently proposed to occur through
mechanotransduction, are not dependent on PIEZO1.
Piezo1 Activation Induced Cytoskeletal and Cell–Cell Adhesion Remodeling
in Cultured LECs. Our in vivo data suggest that PIEZO1 is involved
in the protrusion process of lymphatic valves, which was previously
shown to be associated with remodeling of the cytoskeleton and
Fig. 2. Reduced number of lymphatic valves in endothelial-specific Piezo1
cKO mice. (A and C) Prox1 and integrin α9 immunostaining in P4 mesentery
of WT, Tie2Cre;Piezo1cKO (A) or Lyve1Cre;Piezo1cKO mice (C). Arrowheads
indicate lymphatic valves marked by Prox1 and integrin α9. (Scale bar:
100 μm.) (B and D) Number of lymphatic valves per area in P4 mesentery.
Mean ± SEM n = 4 for both WT and Tie2Cre;Piezo1cKO samples, **P < 0.01
(B). n = 6 for WT, n = 4 for Lyve1Cre;Piezo1cKO samples, ****P < 0.0001 (D),
unpaired t test.
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cell–cell junctions (39, 40). To test whether the activation of
PIEZO1 can affect these components in LECs, we used Yoda1, a
chemical agonist of PIEZO1, but not of PIEZO2 (42, 43). Before
Yoda1 administration, actin fibers associated with phospho-myosin
light chain 2 (pMLC2) were abundantly observed in cultured
LECs, while VE-cadherin+ cell–cell adhesion appeared punctate.
To activate PIEZO1, we used Yoda1 at 1.5 μM. This represents a
moderate stimulus as the EC50 of Yoda1 activation of PIEZO1 is
∼25 μM. Treatments with higher concentrations, such as 5 μM,
resulted in detachment of LECs (SI Appendix, Fig. S4 A and B).
When LECs were exposed to 1.5 μM Yoda1 for 1 h, drastic
changes were observed in the LEC morphology described above
(Fig. 5A). The abundant F-actin stress fibers reorganized into
predominantly cortical actin structures. pMLC2 signal was greatly
reduced, and VE-cadherin+ cell–cell boundaries were straightened.
Continued exposure to Yoda1 (16 h) led to further changes in cell
morphology. LECs now became elongated with F-actin stress fibers
and pMLC2 signals, while VE-cadherin+ cell–cell adhesion was
poorly formed. These LECs often overlapped each other. These
effects of Yoda1 were suppressed by knockdown of PIEZO1 in-
duced by siRNA treatment, confirming that these changes in F-
actin, pMLC2, and VE-cadherin are dependent on PIEZO1 acti-
vation (Fig. 5 B and C and SI Appendix, Fig. S4C). These data
suggest that activation of PIEZO1 in LECs can induce remodeling
of actomyosin and/or VE-cadherin+ cell–cell adhesion.
Discussion
Lymphatic valves are an essential structure for proper flow of the
lymph throughout the body. In this study, by utilizing mouse lines
lacking PIEZO1 in endothelial cells, we show that PIEZO1 is
Fig. 3. Impaired lymphatic valve protrusion in
Tie2Cre;Piezo1cKO mice. (A) E18.5 mesentery with
Prox1 staining. (Scale bar: 100 μm.) (B) Number of
VFRs (containing n ≥ 10 Prox1high nuclei) per area in
E18.5 mesentery. Mean ± SEM (n = 4 for WT, n = 5
for Tie2Cre;Piezo1cKO embryos). P = 0.35, unpaired
t test. (C) Stages of lymphatic valve formation. Stage
2: there are n < 5 reoriented Prox1high nuclei and the
vessel is not constricted. Stage 2.5: n ≥ 5 Prox1high
nuclei are reoriented but the vessel is not con-
stricted. Stages 3 and 4: n ≥ 5 Prox1high nuclei are
reoriented and the vessel is constricted. (D) Per-
centage of each stage among VFRs in E18.5 mesen-
tery. n = 17 VFRs from four embryos per genotype.
*P < 0.05, χ2 test. (E) Representative images of VFRs
in E18.5 mesentery. Yellow lines (Top, side view)
show where images were optically cross-sectioned
(Middle) and schematic illustration of distribution
of Prox1high nucleus (green), VE-cadherin (red), and
F-actin (blue) signals (Bottom). Dotted lines de-
marcate lymphatic vessels. (Scale bar: 100 μm.) (F–H)
Percentage of VFRs in E18.5 mesentery in which
several Prox1high nuclei (F), VE-cadherin (G), or F-
actin (H) signal was located in the more central re-
gions than Prox1high nuclei on the vessel wall. Right
shows examples of patterns of each signal. n = 10
images from four WT embryos, n = 14 images from
four Tie2Cre;Piezo1cKO embryos. *P < 0.05, χ2 test.
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required for the formation of lymphatic valves. These knockout
mice also exhibited pleural effusion, possibly leading to collapsed
alveoli, and difficulty in breathing, which might cause the le-
thality of these mice. These phenotypes bear a strong re-
semblance to what was observed in human patients with familial
lymphatic dysfunctions associated with loss-of-function variants
of PIEZO1 (9–11). It is worth noting that in those patients, deep
rerouting of lymph was observed in the lower limbs, likely
resulted from attenuated drainage by superficial lymphatic
vessels (10). These data suggest that the function of PIEZO1 in
the lymphatic system is likely to be conserved between human
and mouse.
The severity of phenotypes associated with loss-of-function
PIEZO1 mutations in patients covers a wide range. Some pa-
tients survive to adulthood, while others experience fetal or
neonatal demise due to severe tissue edema sometimes char-
acterized as fetal or neonatal hydrops (9–11). As varying se-
verity was reported between siblings carrying the same PIEZO1
variants, there may be genetic modifiers or environmental ef-
fects, which might also explain the phenotypic difference be-
tween Tie2Cre;Piezo1cKO mice of our colony and one previously
reported (11, 25).
Mechanotransduction plays an essential role in the devel-
opment, maintenance, and function of the vasculature. Here,
we show that PIEZO1 is one of the mechanosensors required
for lymphatic and venous valve formation, likely playing a role
during the valve protrusion process. However, our data do not
exclude the possibility that phenotypes other than impaired
valve formation contribute to the phenotypes observed in the
mutant mice. In contrast, we find that PIEZO1 is dispensable
for early events in valve development, as the up-regulation of
FOXC2 and NFATc1, key transcription factors in valve devel-
opment that are up-regulated by oscillatory shear stress in
cultured LECs, were not affected in Tie2Cre;Piezo1cKO mice
(7, 8). Our in vivo data are in line with previous findings
showing that knockdown of PIEZO1 and/or PIEZO2 does not
affect transcriptional up-regulation of FOXC2, Cx37, Integrin
α9, or GATA2 induced by oscillatory shear stress (8). These
data suggest that there are at least two different mechano-
transduction pathways involved in the formation of lymphatic
valves. The identity of the other mechanosensor required for
initiation of valve formation remains unknown.
Our in vitro data suggest that activation of PIEZO1 can induce
dynamic remodeling of actomyosin and/or VE-cadherin+ cell–cell
adhesion in LECs. It is important to note, however, that we do not
present data showing whether mechanical forces relevant for LECs
Fig. 4. Expression of transcription factors involved in initiation of valve
development in Tie2Cre;Piezo1cKO mice. (A and B) FOXC2 (A) or NFATc1 (B)
with Prox1 staining in E17.5 mesentery of WT or Tie2Cre;Piezo1cKO embryos.
Insets show magnified images. FOXC2: n = 8 for WT, n = 7 for Tie2Cre;
Piezo1cKO embryos. NFATc1: n = 7 for WT, n = 6 for Tie2Cre;Piezo1cKO em-
bryos. (Scale bar: 100 μm.)
Fig. 5. PIEZO1 activation-induced changes in actomyosin and VE-cadherin+ cell–
cell adhesion in cultured LECs. (A) Staining of F-actin, pMLC2, and VE-cadherin in
LECs treated with 1.5 μM Yoda1 for 0, 1, or 16 h. (Scale bar: 50 μm.) (B and C)
Staining of F-actin, pMLC2, and VE-cadherin in LECs treated with control (B) or
PIEZO1 siRNA (C) before Yoda1 administration. n = 2 experiments.
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during valve formation are sufficient to induce the changes we
observe by Yoda1. Future experiments will address this issue.
Nevertheless, as Yoda1 was administrated, VE-cadherin+ cell–
cell junctions changed their form from punctate into straight-
ened ones. These structures may have similarities to previously
reported focal adherens junction (also called punctate or dis-
continuous) and linear adherens junction (also called continu-
ous); the former is connected to radial actin bundles that pull on
the cadherin–catenin complex, and the latter is supported by
cortical parallel actin bundles (44, 45). As implied by the change
in the amount of pMLC2, contracting force on actomyosin might
be attenuated by Yoda1-induced PIEZO1 activation.
The effect of PIEZO1 on cellular shape or migration has been
reported in BECs and other cell types (15, 25). In BECs, it is sug-
gested that the effect of PIEZO1 on cell alignment against flow is
through calpain-induced remodeling of focal adhesion (25). In CHO
cells ectopically expressing α4β1 integrin, PIEZO1-dependent in-
tracellular calcium increase is suggested to negatively regulate pro-
tein kinase A, which in turn modulates proteins, including Rac1, a
modulator of F-actin dynamics (46). While the molecular mecha-
nisms through which PIEZO1 activation leads to the remodeling of
cytoskeleton and/or cell–cell adhesion in LECs remain to be de-
termined, regulation of these cellular components is likely the key
for valve morphogenesis. Together, our data highlight the require-
ment of mechanosensor channel PIEZO1 in the formation of lym-
phatic valves, an essential structure for lymph circulation.
Methods
All animal procedures were approved by The Scripps Research Institute,
National Institute for Basic Biology, and University of Pennsylvania In-
stitutional Animal Care and Use Committees. Detailed methods are provided
in SI Appendix, SI Materials and Methods.
Antibodies and Dyes. The following antibodies and dyes were used: Prox1
(1:200, 76696; abcam), integrin α9 (10 μg/mL, AF3827; R&D Systems), FOXC2
(10 μg/mL, AF3827; R&D Systems), NFATc1-488 (1:50, 649604; BioLegend),
mVE-cadherin (1:200, 555289; BD Biosciences), hVE-cadherin (3 μg/mL,
AF938; R&D Systems), pMLC2 (1:300, 3675; Cell Signaling Technology), and
Phalloidin-594 (1:200, A12381; Thermo Fisher Scientific).
Chemically Induced Piezo1 Activation. Round-shaped cover glasses (Matsu-
nami) were coated with 20 μg/mL human plasma fibronectin (Millipore) in
PBS, then LECs were seeded onto slides and grew to 80–100% confluence.
Culture medium was replaced with one containing 1.5 μM Yoda1 (Sigma).
After 1 or 16 h, medium was washed out and fixed with 4% PFA for 15 min.
Immunostaining was performed as previously described (15).
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